HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Candelario-Jalil Selected Research

Oxygen (Dioxygen)

1/2018Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Candelario-Jalil Research Topics

Disease

28Ischemic Stroke
05/2024 - 11/2003
28Stroke (Strokes)
05/2024 - 05/2004
19Brain Injuries (Brain Injury)
12/2023 - 02/2002
18Ischemia
01/2020 - 02/2002
16Brain Ischemia (Cerebral Ischemia)
01/2020 - 10/2002
15Infarction (Infarctions)
05/2024 - 11/2003
13Neuroinflammatory Diseases
04/2024 - 04/2009
10Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2023 - 11/2003
7Inflammation (Inflammations)
06/2022 - 07/2008
4Hypoxia (Hypoxemia)
01/2023 - 11/2013
4Alzheimer Disease (Alzheimer's Disease)
12/2019 - 02/2006
4Edema (Dropsy)
04/2014 - 11/2007
3Cerebral Infarction
02/2008 - 05/2004
3Reperfusion Injury
02/2008 - 04/2002
2Nervous System Diseases (Neurological Disorders)
01/2023 - 03/2013
2Cognitive Dysfunction
01/2023 - 05/2011
2Insulin Resistance
01/2023 - 01/2016
2Central Nervous System Diseases (CNS Diseases)
01/2023 - 01/2021
2Prion Diseases (Transmissible Spongiform Encephalopathies)
10/2021 - 02/2006
2Herpes Zoster
01/2018 - 04/2014
2Neuroblastoma
11/2017 - 09/2009
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2010 - 08/2005
2Necrosis
08/2008 - 07/2008
2Astrocytoma (Pilocytic Astrocytoma)
02/2006 - 05/2005
2Encephalitis (Encephalitis, Rasmussen)
02/2006 - 08/2005
1Congenital Heart Defects (Congenital Heart Defect)
12/2023
1Porcine Reproductive and Respiratory Syndrome (PRRS)
09/2023
1Brain Edema (Cerebral Edema)
01/2023
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2021
1Scrapie
10/2021
1Dementia (Dementias)
08/2021

Drug/Important Bio-Agent (IBA)

14Neuroprotective AgentsIBA
05/2024 - 10/2003
11Matrix Metalloproteinases (MMPs)IBA
01/2022 - 11/2007
7Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2017
7ProstaglandinsIBA
01/2018 - 08/2005
6Peptides (Polypeptides)IBA
01/2023 - 11/2013
6nimesulide (Aulin)IBA
04/2008 - 10/2002
6Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
02/2007 - 02/2002
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2020 - 05/2004
5Dinoprostone (PGE2)FDA Link
12/2015 - 08/2003
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2024 - 03/2013
3Tight Junction ProteinsIBA
01/2023 - 04/2014
3LipidsIBA
01/2023 - 10/2003
3CytokinesIBA
06/2022 - 01/2017
3Tyrosine (L-Tyrosine)FDA Link
01/2021 - 11/2013
3p38 Mitogen-Activated Protein KinasesIBA
01/2021 - 05/2005
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2020 - 11/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2008 - 11/2007
3Prostaglandins EIBA
08/2008 - 05/2004
2Protein Kinases (Protein Kinase)IBA
05/2024 - 09/2023
2InterleukinsIBA
12/2023 - 11/2022
2cresyl violetIBA
09/2023 - 01/2023
2Immunoglobulin G (IgG)IBA
01/2023 - 01/2017
2ChemokinesIBA
06/2022 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
06/2022 - 05/2005
2Protein Isoforms (Isoforms)IBA
10/2021 - 08/2003
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021 - 11/2013
2OccludinIBA
01/2020 - 01/2018
2lipoxin A4IBA
01/2017 - 04/2014
2Glucose (Dextrose)FDA LinkGeneric
01/2017 - 01/2016
2methyl ester 5(S),6(R)-7-trihydroxyheptanoic acidIBA
01/2017 - 04/2014
2EnzymesIBA
09/2009 - 01/2008
2ResveratrolIBA
09/2009 - 10/2007
2Serotonin (5 Hydroxytryptamine)IBA
08/2008 - 05/2005
2Interleukin-1beta (Interleukin 1 beta)IBA
08/2008 - 02/2006
2Malondialdehyde (Propanedial)IBA
07/2008 - 10/2003
2AntioxidantsIBA
07/2008 - 10/2005
2Peroxidase (Myeloperoxidase)IBA
07/2008 - 02/2007
2SalicylatesIBA
02/2007 - 08/2003
2OzoneIBA
10/2005 - 04/2002
2Glutathione (Reduced Glutathione)IBA
10/2003 - 08/2003
1AlbuminsIBA
05/2024
1salicylhydroxamic acid (SHAM)IBA
05/2024
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
04/2024
1Chemokine CCL26IBA
12/2023
1Chemokine CCL11IBA
12/2023
1Interleukin-18 (Interleukin 18)IBA
12/2023
1Biomarkers (Surrogate Marker)IBA
12/2023
1Pattern Recognition ReceptorsIBA
09/2023
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2023
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2023
1triphenyltetrazoliumIBA
01/2023
1CannabidiolIBA
01/2023
1PPAR gammaIBA
01/2023
1RNA (Ribonucleic Acid)IBA
11/2022
1Fatty Acids (Saturated Fatty Acids)IBA
11/2022
1Tricarboxylic AcidsIBA
11/2022
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
06/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2022
1Cell Adhesion MoleculesIBA
01/2022
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2021
1Prion ProteinsIBA
10/2021
1Messenger RNA (mRNA)IBA
08/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021

Therapy/Procedure

11Therapeutics
12/2023 - 10/2005
4Treatment Delay
01/2023 - 10/2003
3Intravenous Injections
01/2018 - 04/2014
2Intravenous Administration
01/2021 - 04/2014
1Drug Therapy (Chemotherapy)
05/2024
1Mechanical Thrombolysis
01/2021